TOB1 could inhibit the proliferation and metastasis of lung cancer cells through a series of downstream regulators, including cyclin D1, AKT signal transduction, BCL-2, BCL-XL, and SMAD4 [47]. Here, AKT1 is linked to lung carcinoma.